These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6869178)

  • 1. Ventricular fibrillation following verapamil in the Wolff-Parkinson-White syndrome.
    Gulamhusein S; Ko P; Klein GJ
    Am Heart J; 1983 Jul; 106(1 Pt 1):145-7. PubMed ID: 6869178
    [No Abstract]   [Full Text] [Related]  

  • 2. [Wolff-Parkinson-White syndrome and verapamil: apropos of a case of ventricular fibrillation].
    Michel B; Goy JJ; Kappenberger L
    Schweiz Med Wochenschr; 1989 May; 119(19):630-4. PubMed ID: 2740877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [2 episodes of ventricular fibrillation in a patient with mild paroxysms of Wolff-Parkinson-White syndrome].
    Walczak F; Nyznyk M; Biederman A; Jedynak Z; Bujnowska E
    Kardiol Pol; 1992 Nov; 37(11):311-3. PubMed ID: 1287293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation in the Wolff-Parkinson-White syndrome: effects of verapamil and procainamide.
    Laufer N; Crevey B
    Ariz Med; 1985 Mar; 42(3):150-3. PubMed ID: 3994532
    [No Abstract]   [Full Text] [Related]  

  • 5. Precipitation of cardiac arrest by verapamil in patients with Wolff-Parkinson-White syndrome.
    McGovern B; Garan H; Ruskin JN
    Ann Intern Med; 1986 Jun; 104(6):791-4. PubMed ID: 3706931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of isoptin in auricular fibrillation in a patient with Wolff-Parkinson-White syndrome].
    Golitsyn SP; Sokolov SF; Mazur NA
    Kardiologiia; 1979 Jul; 19(7):102-5. PubMed ID: 470312
    [No Abstract]   [Full Text] [Related]  

  • 7. Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil.
    Gulamhusein S; Ko P; Carruthers SG; Klein GJ
    Circulation; 1982 Feb; 65(2):348-54. PubMed ID: 7053894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal ventricular fibrillation following verapamil in Wolff-Parkinson-White syndrome with atrial fibrillation.
    Jacob AS; Nielsen DH; Gianelly RE
    Ann Emerg Med; 1985 Feb; 14(2):159-60. PubMed ID: 3970402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil in atrial fibrillation: The expected, the unexpected, and the unknown.
    Schwartz JB
    Am Heart J; 1983 Jul; 106(1 Pt 1):173-6. PubMed ID: 6869191
    [No Abstract]   [Full Text] [Related]  

  • 10. Deleterious effects of intravenous verapamil in Wolff-Parkinson-White patients and atrial fibrillation.
    Strasberg B; Sagie A; Rechavia E; Katz A; Ovsyscher IA; Sclarovsky S; Agmon J
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):801-6. PubMed ID: 2488095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented ventricular rate following verapamil treatment for atrial fibrillation with Wolff-Parkinson-White syndrome.
    Rowland TW
    Pediatrics; 1983 Aug; 72(2):245-6. PubMed ID: 6866612
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular fibrillation after intravenous amiodarone in Wolff-Parkinson-White syndrome with atrial fibrillation.
    Boriani G; Biffi M; Frabetti L; Azzolini U; Sabbatani P; Bronzetti G; Capucci A; Magnani B
    Am Heart J; 1996 Jun; 131(6):1214-6. PubMed ID: 8644602
    [No Abstract]   [Full Text] [Related]  

  • 13. Verapamil induced premature ventricular beats before reversion of supraventricular tachycardia.
    Vohra J; Peter T; Hunt D; Sloman G
    Br Heart J; 1974 Dec; 36(12):1186-93. PubMed ID: 4441450
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
    Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
    Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Verapamil nowadays].
    Piccolo E; Ferrari M
    G Ital Cardiol; 1977; 7(3):300-3. PubMed ID: 858467
    [No Abstract]   [Full Text] [Related]  

  • 16. Precipitation of ventricular fibrillation by intravenous diltiazem and metoprolol in a young patient with occult Wolff-Parkinson-White syndrome.
    Kim RJ; Gerling BR; Kono AT; Greenberg ML
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):776-9. PubMed ID: 18507555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular fibrillation associated with use of digitalis in a newborn infant with Wolff-Parkinson-White syndrome.
    Byrum CJ; Wahl RA; Behrendt DM; Dick M
    J Pediatr; 1982 Sep; 101(3):400-3. PubMed ID: 7202043
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A; Peter T; Platt M; Mandel WJ
    Am Heart J; 1981 May; 101(5):600-12. PubMed ID: 7223599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of verapamil on electrophysiological properties of anomalous atrioventricular connexion in Wolff-Parkinson-White syndrome.
    Spurrell RA; Krikler DM; Sowton E
    Br Heart J; 1974 Mar; 36(3):256-64. PubMed ID: 4824534
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical use of verapamil.
    Vohra JK
    Drugs; 1977 Mar; 13(3):219-24. PubMed ID: 321206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.